The Major Chromoblastomycosis Etiologic Agent Fonsecaea pedrosoi Activates the NLRP3 Inflammasome

The Major Chromoblastomycosis Etiologic Agent Fonsecaea pedrosoi Activates the NLRP3 Inflammasome

Fonsecaea pedrosoi is the main etiologic agent of chromoblastomycosis (CBM), one of the most prevalent subcutaneous mycosis in tropical and subtropical countries. CBM is a poorly characterized chronic infection that commonly starts after transcutaneous inoculation of conidia and saprophytic hyphae o...

Full description

Bibliographic Details
Main Authors:	Raffael Júnio Araújo de Castro, Isaque Medeiros Siqueira, Márcio Sousa Jerônimo, Angelina Maria Moreschi Basso, Paulo Henrique de Holanda Veloso Junior, Kelly Grace Magalhães, Luiza Chaves Leonhardt, Stephan Alberto Machado de Oliveira, Pedro Henrique Bürgel, Aldo Henrique Tavares, Anamélia Lorenzetti Bocca
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-11-01
Series:	Frontiers in Immunology
Subjects:	NLRP3 inflammasome Fonsecaea pedrosoi chromoblastomycosis hyphae macrophages dendritic cells
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.01572/full

Similar Items

Corneal Chromoblastomycosis Caused by Fonsecaea pedrosoi
by: Winai Chaidaroon, et al.
Published: (2015-02-01)

Experimental murine chromoblastomycosis obtained from Fonsecaea pedrosoi isolate cultured for a long periodt
by: AP Machado, et al.
Published: (2009-01-01)

Etymologia: Fonsecaea pedrosoi
by: Dayane Moraes, et al.
Published: (2023-07-01)

Cromoblastomicose produzida por Fonsecaea pedrosoi no Estado do Maranhão. I - aspectos clínicos, epidemiológicos e evolutivos
by: Ana Carla C. Mello e Silva, et al.
Published: (1992-03-01)

A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine
by: Xu-Cheng Shen, et al.
Published: (2020-02-01)

Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole
by: Nora Cardona-Castro, et al.
Published: (1996-12-01)

Chromoblastomycosis Treatment With Combination Therapy of Itraconazole (Pulse Dose) and Cryotherapy
by: Nugrohoaji Dharmawan, et al.
Published: (2021-12-01)

Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors
by: Vanila F. Palmeira, et al.
Published: (2018-06-01)

HIV Aspartic Peptidase Inhibitors Modulate Surface Molecules and Enzyme Activities Involved with Physiopathological Events in Fonsecaea pedrosoi
by: Vanila F. Palmeira, et al.
Published: (2017-05-01)

Fonsecaea Pedrosoi: A Rare Etiology in Fungal Keratitis
by: Jyoti Sangwan, et al.
Published: (2013-10-01)

Immune Sensing and Potential Immunotherapeutic Approaches to Control Chromoblastomycosis
by: Leandro C. D. Breda, et al.
Published: (2020-12-01)

Comparative Genomics of Sibling Species of Fonsecaea Associated with Human Chromoblastomycosis
by: Vania A. Vicente, et al.
Published: (2017-10-01)

Cromoblastomicose produzida por Fonsecaea pedrosoi no Estado do Maranhão. I - aspectos clínicos, epidemiológicos e evolutivos
by: Ana Carla C. Mello e Silva, et al.
Published: (1992-03-01)

Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole
by: Rowena Alves Coelho, et al.
Published: (2023-07-01)

Environmental Screening of <i>Fonsecaea</i> Agents of Chromoblastomycosis Using Rolling Circle Amplification
by: Morgana Ferreira Voidaleski, et al.
Published: (2020-11-01)

A Model for Trans-Kingdom Pathogenicity in Fonsecaea Agents of Human Chromoblastomycosis
by: Gheniffer Fornari, et al.
Published: (2018-10-01)

Melanin particles isolated from the fungus Fonsecaea pedrosoi activates the human complement system
by: Lysianne Pinto, et al.
Published: (2018-06-01)

Pathogenicity and Growth Conditions Modulate Fonsecaea Extracellular Vesicles’ Ability to Interact With Macrophages
by: Lucas de Oliveira Las-Casas, et al.
Published: (2022-06-01)

First case of chromoblastomycosis from Bangladesh
by: Brun Sophie, et al.
Published: (2015-12-01)

Chromoblastomycosis due to Fonsecaea monophora misdiagnosed as sporotrichosis and cutaneous tuberculosis in a pulmonary tuberculosis patient
by: Dongmei Shi, et al.
Published: (2016-03-01)

Bacillus subtilis induces morphological changes in Fonsecaea pedrosoi in vitro resulting in more resistant fungal forms in vivo
by: AP Machado, et al.
Published: (2010-01-01)

Extraction and virulence analysis of melanin from Fonsecaea monophora
by: Huan HUANG, et al.
Published: (2023-06-01)

Chromoblastomycosis: A rare fungal infection from a nonendemic region—Southern Odisha
by: Akash Panigrahi, et al.
Published: (2020-01-01)

O babaçu (Orbignya phalerata martins) como provável fator de risco de infecção humana pelo agente da cromoblastomicose no Estado do Maranhão, Brasil
by: Conceição de Maria P. e Silva, et al.
Published: (1995-03-01)

Molecular Epidemiology of Fonsecaea Species
by: Mohammad Javad Najafzadeh, et al.
Published: (2011-03-01)

Modulation of the immune response by Fonsecaea pedrosoi morphotypes in the course of experimental chromoblastomycosis and their role on inflammatory response chronicity.
by: Isaque Medeiros Siqueira, et al.
Published: (2017-03-01)

Chromoblastomycosis in an Endemic Area of Brazil: A Clinical-Epidemiological Analysis and a Worldwide Haplotype Network
by: Daniel Wagner C. L. Santos, et al.
Published: (2020-10-01)

<i>Agrobacterium tumefaciens</i>-Mediated Transformation of <i>Fonsecaea monophora</i> and <i>Fonsecaea erecta</i> for Host-Environment Interaction Studies
by: Cristina Isabel Ferrer Villena, et al.
Published: (2020-11-01)

Does DHN-Melanin Always Protect Fungi against Antifungal Drugs? The <i>Fonsecaea</i>/Micafungin Paradigm
by: Rowena Alves Coelho, et al.
Published: (2022-05-01)

Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus <i>Fonsecaea</i> sp.
by: Jorge Augusto Leão Pereira, et al.
Published: (2022-08-01)

Molecular Characteristics of Regional Chromoblastomycosis in Guangdong, China: Epidemiological, Clinical, Antifungal Susceptibility, and Serum Cytokine Profiles of 45 Cases
by: Hongfang Liu, et al.
Published: (2022-02-01)

O babaçu (Orbignya phalerata martins) como provável fator de risco de infecção humana pelo agente da cromoblastomicose no Estado do Maranhão, Brasil
by: Conceição de Maria P. e Silva, et al.
Published: (1995-03-01)

Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar
by: Tahinamandranto Rasamoelina, et al.
Published: (2020-06-01)

Cromoblastomicose no Rio Grande do Sul: relato de 12 casos
by: Matte Shirley M.W., et al.
Published: (1997-01-01)

Study of tissue inflammatory response in different mice strains infected by dematiaceous fungi Fonsecaea pedrosoi
by: Marilia Marufuji Ogawa, et al.
Published: (2019-02-01)

Zinc Starvation Induces Cell Wall Remodeling and Activates the Antioxidant Defense System in <i>Fonsecaea pedrosoi</i>
by: Tayná Aparecida de Oliveira Santos, et al.
Published: (2024-01-01)

Úlcera corneal por Fonsecaea pedrosoi, las dificultades del tratamiento de un germen desafiante: reporte de caso
by: Claudia Martínez-Córdoba, et al.
Published: (2022-07-01)

Dermoscopy of chromoblastomycosis
by: Sweta Subhadarshani, et al.
Published: (2017-10-01)

Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal clearance in later stage of experimental chromoblastomycosis.
by: Isaque Medeiros Siqueira, et al.
Published: (2020-06-01)

Response of chromoblastomycosis to voriconazole
by: Alexandre Moretti de Lima, et al.
Published: (2016-10-01)